{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T01:58:54Z","timestamp":1725760734461},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1987]]},"DOI":"10.1007\/bf00606632","type":"journal-article","created":{"date-parts":[[2004,11,24]],"date-time":"2004-11-24T13:06:14Z","timestamp":1101301574000},"page":"569-573","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of persistent fetal circulation syndrome of the newborn. Comparison of different doses of tolazoline"],"prefix":"10.1007","volume":"31","author":[{"given":"P.","family":"Monin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dubruc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. L.","family":"Morselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-3476(76)80403-9","volume":"89","author":"BW Goetzman","year":"1976","unstructured":"Goetzman BW, Sunshine P, Johnson JD et al (1976) Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline. J Pediatr 89: 617?621","journal-title":"J Pediatr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1203\/00006450-197908000-00014","volume":"13","author":"BW Goetzman","year":"1979","unstructured":"Goetzman BW, Milstein JM (1979) Pulmonary vasodilator action of tolazoline. Pediatr Res 13: 942?944","journal-title":"Pediatr Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.0954-6820.1971.tb07416.x","volume":"190","author":"AM Abrahamsen","year":"1971","unstructured":"Abrahamsen AM (1971) Hemodynaic effects of tolazoline: Studies in normal subjects and patients, with mitral valvular disease, congenital heart. Acta Med Scand 190: 199?203","journal-title":"Acta Med Scand"},{"key":"CR4","first-page":"217","volume":"123","author":"MA Bressak","year":"1981","unstructured":"Bressak MA, Bland RD (1981) Intravenous infusion of tolazoline reduces pulmonary vascular resistances and net fluid filtration in the lung of awake, hypoxic newborn lambs. Am Rev Respir Dis 123: 217?221","journal-title":"Am Rev Respir Dis"},{"key":"CR5","first-page":"59","volume":"4","author":"WH Drummond","year":"1984","unstructured":"Drummond WH, Williams B, Webb I (1984) Circulatory effects of tolazoline and prostacyclin (PG12) in chronically instrumented lambs. Pediatr Pharmacol 4: 59?72","journal-title":"Pediatr Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-8703(61)90510-5","volume":"61","author":"RF Grover","year":"1961","unstructured":"Grover RF, Reeves JT, Blount SG (1961) Tolazoline hydrochloride (Priscoline) an effective pulmonary dilatator. Am Heart J 61: 5?15","journal-title":"Am Heart J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3476(79)80778-7","volume":"95","author":"JE Lock","year":"1979","unstructured":"Lock JE, Coceani F, Olley PM (1979) Direct and indirect pulmonary vascular effect of tolazoline in the newborn lambs. J Pediatr 95: 600?605","journal-title":"J Pediatr"},{"key":"CR8","first-page":"271","volume":"89","author":"RP Ahlquist","year":"1947","unstructured":"Ahlquist RP, Huggins RA, Woodbury RA (1947) The pharmacology of benzylimidazol (Priscol). J Pharmacol Exp Ther 89: 271?288","journal-title":"J Pharmacol Exp Ther"},{"key":"CR9","first-page":"54","volume":"1","author":"M Nickerson","year":"1949","unstructured":"Nickerson M (1949) The pharmacology of adrenergic blockade. Pharmacol Rev 1: 54?58","journal-title":"Pharmacol Rev"},{"key":"CR10","first-page":"474","volume":"219","author":"RP Keenakin","year":"1981","unstructured":"Keenakin RP, Angus JA (1981) The histamin like effects of tolazoline and clinidine: Evidence against direct activity of histamine receptors. J Pharmacol Exp Ther 219: 474?480","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01969977","volume":"7","author":"MJ Hugues","year":"1977","unstructured":"Hugues MJ, O'Brien LJ (1977) Liberation of endogenous compounds by tolazoline. Agents Actions 7: 225?230","journal-title":"Agents Actions"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0095-5108(18)30912-6","volume":"113","author":"RM Ward","year":"1984","unstructured":"Ward RM (1984) Pharmacology of tolazoline. Clin Perinatol 113: 703?713","journal-title":"Clin Perinatol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01969971","volume":"7","author":"S Verma","year":"1977","unstructured":"Verma S, McNeill JH (1977) Investigations into the cardiac effects of tolazoline in guinea pig atria and ventricular strips. Agents Actions 7: 191?197","journal-title":"Agents Actions"},{"key":"CR14","first-page":"156","volume":"116","author":"BK Lum","year":"1956","unstructured":"Lum BK, Nickerson M (1956) Cardiac arythmia induced tolazoline. J Pharmacol Exp Ther 116: 156?163","journal-title":"J Pharmacol Exp Ther"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM195302122480703","volume":"248","author":"EL Segall","year":"1953","unstructured":"Segall EL, Lewenstein HJ (1953) Prolonged cardiac pain following the intra-atrial injection of priscoline: Report of case. N Engl J Med 248: 278","journal-title":"N Engl J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0161-4630(81)90024-0","volume":"7","author":"MD Starling","year":"1981","unstructured":"Starling MD, Neutze JM, Elliot RL, Elliot RB (1981) Comparative studies on the hemodynamic effects of prostaglandins E1. Prostacyclin and tolazoline upon elevated pulmonary vascular resistance in neonatal swine. Prostaglandins Med 7: 349?361","journal-title":"Prostaglandins Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000457367","volume":"41","author":"P Monin","year":"1982","unstructured":"Monin P, Vert P, Morselli PL (1982) A pharmacodynamic and pharmakinetic study of tolazoline in the neonate. Dev Pharmacol Ther 41: 124?128","journal-title":"Dev Pharmacol Ther"},{"key":"CR18","first-page":"143","volume-title":"Intensive care of the newborn","author":"P Monin","year":"1983","unstructured":"Monin P, Vert P, Rovei V, Morselli PL (1983) Persistance of the fetal circulation. The pharmacodynamic effects and kinetics of tolazoline. In: Stern L, Bard H, Fris-Hansen B (eds) Intensive care of the newborn. Masson, Paris, p 143"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0378-4347(00)80529-0","volume":"231","author":"V Rovei","year":"1982","unstructured":"Rovei V, Remones G, Thenot JP, Morselli PL (1982) Determination of tolazoline in plasma by high performance liquide chromatography. J Chromatogr 231: 210?214","journal-title":"J Chromatogr"},{"key":"CR20","first-page":"231","volume":"2","author":"A Tucker","year":"1982","unstructured":"Tucker A, Brown DT, Greenlees KJ (1982) Pulmonary and systemic vascular actions of tolazoline in anesthetized dogs. Pediatr Pharmacol 2: 231?243","journal-title":"Pediatr Pharmacol"},{"key":"CR21","first-page":"115","volume":"4","author":"A Tucker","year":"1984","unstructured":"Tucker A, Greenlees KJ, Gotshall RW (1984) Pulmonary and systemic vascular response to tolazoline in neonatal and mature calves. Pediatr Pharmacol 4: 115?128","journal-title":"Pediatr Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00606632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00606632\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00606632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:23:46Z","timestamp":1554434626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00606632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987]]}},"alternative-id":["BF00606632"],"URL":"https:\/\/doi.org\/10.1007\/bf00606632","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987]]}}}